CoChat

Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment–Elevation Myocardial Infarction: The MIMI Study

Belle, Loic, Motreff, Pascal, Mangin, Lionel, Rangé, Grégoire, Marcaggi, Xavier, Marie, Antoine, Ferrier, Nadine, Dubreuil, Olivier, Zemour, Gilles, Souteyrand, Géraud, Caussin, Christophe, Amabile, Nicolas, Isaaz, Karl, Dauphin, Raphael, Koning, René, Robin, Christophe, Faurie, Benjamin, Bonello, Laurent, Champin, Stanislas, Delhaye, Cédric, Cuilleret, François, Mewton, Nathan, Genty, Céline, Viallon, Magalie, Bosson, Jean Luc, Croisille, Pierre, on behalf of the MIMI Investigators · 2016 · Circulation: Cardiovascular Interventions
Cited by 96

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background—: Delayed stent implantation after restoration of normal epicardial flow by a minimalist immediate mechanical intervention aims to decrease the rate of distal embolization and impaired myocardial reperfusion after percutaneous coronary intervention. We sought to confirm whether a delayed stenting (DS) approach (24–48 hours) improves myocardial reperfusion, versus immediate stenting, in patients with acute ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary intervention. Methods and Results—: In the prospective, randomized, open-label minimalist immediate mechanical intervention (MIMI) trial, patients (n=140) with ST-segment–elevation myocardial infarction ≤12 hours were randomized to immediate stenting (n=73) or DS (n=67) after Thrombolysis In Myocardial Infarction 3 flow restoration by thrombus aspiration. Patients in the DS group underwent a second coronary arteriography for stent implantation a median of 36 hours (interquartile range 29–46) after randomization. The primary end point was microvascular obstruction (% left ventricular mass) on cardiac magnetic resonance imaging performed 5 days (interquartile range 4–6) after the first procedure. There was a nonsignificant trend toward lower microvascular obstruction in the immediate stenting group compared with DS group (1.88% versus 3.96%; P =0.051), which became significant after adjustment for the area at risk ( P =0.049). Median infarct weight, left ventricular ejection fraction, and infarct size did not differ between groups. No difference in 6-month outcomes was apparent for the rate of major cardiovascular and cerebral events. Conclusions—: The present findings do not support a strategy of DS versus immediate stenting in patients with ST-segment–elevation infarction undergoing primary percutaneous coronary intervention and even suggested a deleterious effect of DS on microvascular obstruction size. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01360242.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circinterventions.115.003388

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Cyclosporine before PCI in Patients with Acute Myocardial Infarction

    Cung, T.-T., Morel, O., Cayla, G., Rioufol, G., Garcia-Dorado, D., Angoulvant, D., Bonnefoy-Cudraz, E., Guérin, P., Elbaz, M., Delarche, N., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505489 · Cited by 713 · cited 1×

    “Recently, cyclosporine failed to demonstrate clinical benefit in patients with an acute myocardial infarction.(27) To be recommended for clinical routine management of STEMI patient, any innovative strategy has to prove a clinical benefit in sufficiently powered phase III clinical studies.”
    BackgroundSelf-citation

Show all 1 references

Cited by

Metadata

Authors
Belle, L., Motreff, P., Mangin, L., Rangé, G., Marcaggi, X., Marie, A., Ferrier, N., Dubreuil, O., Zemour, G., Souteyrand, G., Caussin, C., Amabile, N., Isaaz, K., Dauphin, R., Koning, R., Robin, C., Faurie, B., Bonello, L., Champin, S., Delhaye, C., Cuilleret, F., Mewton, N., Genty, C., Viallon, M., Bosson, J. L., Croisille, P., & on behalf of the MIMI Investigators
Venue
Circulation: Cardiovascular Interventions
Published
2016-03
Volume
9
Issue
3
Pages
e003388-e003388
ISSN
  • 1941-7632 (ISSN-L)
  • 1941-7640
OpenAlex
W2296790217
Cited by
96
References
1
FWCI
9.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.